- Report
- February 2023
- 206 Pages
Global
From €3060EUR$3,185USD£2,616GBP
€4372EUR$4,550USD£3,738GBP
- Report
- February 2021
- 118 Pages
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
- Report
- August 2022
- 115 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- August 2022
- 116 Pages
Global
From €4564EUR$4,750USD£3,902GBP
- Report
- November 2023
- 82 Pages
From €2018EUR$2,100USD£1,725GBP
€2883EUR$3,000USD£2,464GBP
- Report
- April 2021
- 124 Pages
Global
From €4084EUR$4,250USD£3,491GBP
- Report
- October 2022
- 227 Pages
Global
From €3459EUR$3,600USD£2,957GBP
- Report
- July 2022
- 315 Pages
Global
From €5543EUR$5,769USD£4,739GBP
- Report
- April 2024
- 140 Pages
From €4803EUR$4,999USD£4,106GBP
- Report
- April 2024
- 140 Pages
From €5284EUR$5,499USD£4,517GBP
- Book
- June 2018
- 368 Pages
Organoid technology is a rapidly growing field of biotechnology that focuses on the development of three-dimensional (3D) cell cultures that mimic the structure and function of human organs. Organoids are created from stem cells and are used to study the development and function of human organs in a laboratory setting. They are also used to model diseases and test potential treatments.
Organoids are increasingly being used in drug discovery and development, as well as in personalized medicine. They are also being used to study the effects of environmental toxins on human health.
Organoid technology is a rapidly growing field, with many companies investing in the development of new technologies and products. Companies such as Organovo, Emulate, and TissUse are leading the way in the development of organoid technology. Other companies such as InSphero, Mimetas, and 3D Biomatrix are also developing organoid-based products and services. Show Less Read more
